| Year |
Title |
Altmetric |
| 2023
|
Comparative effectiveness of oseltamivir versus peramivir for hospitalized children (aged 0-5 years) with influenza infection.
International Journal of Infectious Diseases.
128:157-165.
2023
|
|
| 2022
|
Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers.
Clinical Cancer Research.
28:5419-5430.
2022
|
|
| 2022
|
Shedding Patterns of Genital Herpes Simplex Virus Infections.
Journal of the American Medical Association.
328:1710-1711.
2022
|
|
| 2022
|
Gastric herpes simplex virus type 1 infection is associated with functional gastrointestinal disorders in the presence and absence of comorbid fibromyalgia: a pilot case–control study
2022
|
|
| 2022
|
Commentary: John C. Martin (1951–2021).
Antiviral Therapy.
27.
2022
|
|
| 2022
|
Molnupiravir - A step toward orally bioavailable therapies for covid-19.
New England Journal of Medicine.
386:592-593.
2022
|
|
| 2022
|
Commentary: Development of Therapeutics for Congenital Cytomegalovirus Infection.
Antiviral Therapy.
27.
2022
|
|
| 2022
|
Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study.
Clinical Cancer Research.
28:498-506.
2022
|
|
| 2022
|
Meeting report: 34th international conference on antiviral research.
Antiviral Chemistry and Chemotherapy.
30.
2022
|
|
| 2021
|
Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.
Journal of Infectious Diseases.
224:1995-2000.
2021
|
|
| 2021
|
Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase.
New England Journal of Medicine.
385:1774-1785.
2021
|
|
| 2021
|
SARS-CoV-2 and the rheumatology patient: The last 12 months and a boost in the future.
Annals of the Rheumatic Diseases.
80:1249-1251.
2021
|
|
| 2021
|
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
Journal of Infectious Diseases.
224:S1-S21.
2021
|
|
| 2021
|
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.
New England Journal of Medicine.
384:1613-1622.
2021
|
|
| 2021
|
Oncolytic HSV-1 G207 immunovirotherapy for pediatric high-grade gliomas.
New England Journal of Medicine.
384:1613-1622.
2021
|
|
| 2020
|
Respiratory Syncytial Virus Antivirals: Problems and Progress.
Journal of Infectious Diseases.
222:1417-1421.
2020
|
|
| 2020
|
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain Tumors.
Human gene therapy. Clinical development.
31:1132-1139.
2020
|
|
| 2020
|
Viral kinetics and resistance development in children treated with neuraminidase inhibitors: The influenza resistance information study (IRIS).
Clinical Infectious Diseases.
71:1186-1194.
2020
|
|
| 2020
|
Resistance of influenza virus to antiviral medications.
Clinical Infectious Diseases.
71:1092-1094.
2020
|
|
| 2020
|
Azithromycin Treatment vs Placebo in Children with Respiratory Syncytial Virus-Induced Respiratory Failure: A Phase 2 Randomized Clinical Trial.
JAMA Network Open.
3.
2020
|
|
| 2020
|
Mark Prichard: Scholar, family man and friend.
Antiviral Research.
176.
2020
|
|
| 2020
|
Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice.
Cancer Gene Therapy.
27:246-255.
2020
|
|
| 2020
|
Advances in the development of therapeutics for cytomegalovirus infections.
Journal of Infectious Diseases.
221:32-44.
2020
|
|
| 2019
|
A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition.
OncoImmunology.
8.
2019
|
|
| 2019
|
Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance.
Oncogene.
38:6159-6171.
2019
|
|
| 2019
|
Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat?
2019
|
|
| 2019
|
Valaciclovir therapy for herpes encephalitis: Caution advised.
Journal of Antimicrobial Chemotherapy.
74:1467-1478.
2019
|
|
| 2019
|
Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.
Journal of Infectious Diseases.
219:1398-1406.
2019
|
|
| 2019
|
Genotypic and phenotypic diversity of herpes simplex virus 2 within the infected neonatal population.
Clinical and Vaccine Immunology.
4.
2019
|
|
| 2019
|
Lack of efficacy of high-titered immunoglobulin in patients with West Nile virus central nervous system disease
2019
|
|
| 2018
|
Comparison of antiviral resistance across acute and chronic viral infections.
Antiviral Research.
158:103-112.
2018
|
|
| 2018
|
Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials.
Clinical Infectious Diseases.
66:1492-1500.
2018
|
|
| 2018
|
Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study.
Influenza and Other Respiratory Viruses.
12:267-278.
2018
|
|
| 2018
|
Clinical management of herpes simplex virus infections: Past, present, and future[version 1; peer review: 2 approved].
F1000Research.
7.
2018
|
|
| 2017
|
Herpes Simplex Encephalitis: an Update.
Current Infectious Disease Reports.
19.
2017
|
|
| 2017
|
Accelerating Drug Development: Antiviral Therapies for Emerging Viruses as a Model.
Annual Review of Pharmacology and Toxicology.
57:155-169.
2017
|
|
| 2017
|
Pathogenesis of Non-Zika Congenital Viral Infections.
Journal of Infectious Diseases.
216:S912-S918.
2017
|
|
| 2016
|
The authors reply.
New England Journal of Medicine.
375:1906.
2016
|
|
| 2016
|
Viral infection in the development and progression of pediatric acute respiratory distress syndrome.
Frontiers in Pediatrics.
4.
2016
|
|
| 2016
|
Update: Interim guidance for the evaluation and management of infants with possible congenital Zika virus infection — United States, August 2016
2016
|
|
| 2016
|
Genital herpes.
New England Journal of Medicine.
375:666-674.
2016
|
|
| 2016
|
Consortia's critical role in developing medical countermeasures for re-emerging viral infections: A USA perspective.
Future Virology.
11:187-195.
2016
|
|
| 2016
|
Oseltamivir for influenza - Authors' reply
2016
|
|
| 2015
|
Herpes Simplex Virus Infections of the Central Nervous System.
CONTINUUM: Lifelong Learning in Neurology.
21:1704-1713.
2015
|
|
| 2015
|
A randomized, double-blind, placebo-controlled trial of pleconaril for the treatment of neonates with enterovirus sepsis.
Journal of the Pediatric Infectious Diseases Society.
5:53-62.
2015
|
|
| 2015
|
Addendum: Kong, M.Y.; Whitley, R.J.; Peng, N.; Oster, R.; Schoeb, T.R.; Sullender, W.; Ambalavanan, N.; Clancy, J.P.; Gaggar, A.; Blalock J.E. Matrix Metalloproteinase-9 Mediates RSV Infection in Vitro and in Vivo. Viruses 2015, 30, 7, 4230–4253..
Viruses.
7:5609.
2015
|
|
| 2015
|
Authors reply
2015
|
|
| 2015
|
Herpes simplex encephalitis: Lack of clinical benefit of long-term valacyclovir therapy.
Clinical Infectious Diseases.
61:683-691.
2015
|
|
| 2015
|
Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease.
Obstetrical and Gynecological Survey.
70:489-490.
2015
|
|
| 2015
|
Matrix metalloproteinase-9 mediates RSV infection in vitro and in vivo.
Viruses.
7:4230-4253.
2015
|
|
| 2015
|
Oseltamivir treatment for influenza in adults: A meta-analysis of randomised controlled trials
2015
|
|
| 2015
|
Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics.
Clinical Infectious Diseases.
60:1377-1383.
2015
|
|
| 2015
|
Challenges and opportunities in developing respiratory syncytial virus therapeutics.
Journal of Infectious Diseases.
211:S1-S20.
2015
|
|
| 2015
|
Waning efficacy of the herpes zoster vaccine.
Clinical Infectious Diseases.
60:910-911.
2015
|
|
| 2015
|
Valganciclovir for symptomatic congenital cytomegalovirus disease.
New England Journal of Medicine.
372:933-943.
2015
|
|
| 2015
|
Single dose peramivir for the treatment of acute seasonal influenza: Integrated analysis of efficacy and safety from two placebo-controlled trials.
Antiviral Therapy.
20:709-719.
2015
|
|
| 2014
|
Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines
2014
|
|
| 2014
|
West Nile virus neuroinvasive disease: Neurological manifestations and prospective longitudinal outcomes.
BMC Infectious Diseases.
14.
2014
|
|
| 2014
|
Erratum: Global assessment of resistance to neuraminidase inhibitors, 2008-2011: The Influenza Resistance Information Study (IRIS) (Clinical Infectious Diseases (2013) 56 (1197-205)).
Clinical Infectious Diseases.
58:1203.
2014
|
|
| 2014
|
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to Aotus Nonhuman Primates.
Human gene therapy. Clinical development.
25:16-27.
2014
|
|
| 2014
|
A novel potential therapy for HSV.
New England Journal of Medicine.
370:273-274.
2014
|
|
| 2014
|
A phase 1 trial of oncolytic HSV-1, g207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses.
Molecular Therapy.
22:1048-1055.
2014
|
|
| 2014
|
Herpes simplex virus.
Handbook of Clinical Neurology.
123:251-263.
2014
|
|
| 2014
|
Oral GS-5806 activity in a respiratory syncytial virus challenge study.
New England Journal of Medicine.
371:711-722.
2014
|
|
| 2014
|
The development of new therapies for human herpesvirus 6.
Current Opinion in Virology.
9:148-153.
2014
|
|
| 2014
|
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.
Clinical Pharmacology and Therapeutics.
96:380-389.
2014
|
|
| 2013
|
Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.
PLoS One.
8.
2013
|
|
| 2013
|
Case definitions, diagnostic algorithms, and priorities in encephalitis: Consensus statement of the international encephalitis consortium.
Clinical Infectious Diseases.
57:1114-1128.
2013
|
|
| 2013
|
An inquiry into the molecular basis of HSV latency and reactivation.
Annual Review of Microbiology.
67:355-374.
2013
|
|
| 2013
|
Viral therapy of glioblastoma multiforme
2013
|
|
| 2013
|
Global assessment of resistance to neuraminidase inhibitors, 2008-2011: The influenza resistance information study (IRIS).
Clinical Infectious Diseases.
56:1197-1205.
2013
|
|
| 2013
|
Erratum: Changing epidemiology of herpes simplex virus infections (Clinical Infectious Diseases (2013) 56 (352-353)).
Clinical Infectious Diseases.
56:1066.
2013
|
|
| 2013
|
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.
Journal of Infectious Diseases.
207:709-720.
2013
|
|
| 2013
|
Editorial commentary: Changing Epidemiology of Herpes Simplex Virus Infections.
Clinical Infectious Diseases.
56:352-353.
2013
|
|
| 2012
|
Predictors of undiagnosed herpes simplex virus type 2 seropositivity among persons attending an HIV care clinic.
Sexually Transmitted Diseases.
39:857-859.
2012
|
|
| 2012
|
Correlation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients.
Pediatric Transplantation.
16:627-637.
2012
|
|
| 2012
|
Preclinical evaluation of a genetically engineered herpes simplex virus expressing interleukin-12.
Journal of Virology.
86:5304-5313.
2012
|
|
| 2012
|
The Use of Antiviral Drugs During the Neonatal Period.
Clinics in Perinatology.
39:69-81.
2012
|
|
| 2012
|
The authors reply.
New England Journal of Medicine.
366:90-91.
2012
|
|
| 2012
|
Current management and recommendations for access to antiviral therapy of herpes labialis.
Journal of Clinical Virology.
53:6-11.
2012
|
|
| 2011
|
Neonatal herpes simplex virus infections: Where are we now?.
Advances in Experimental Medicine and Biology.
697:221-230.
2011
|
|
| 2011
|
Oral acyclovir suppression and neurodevelopment after neonatal herpes.
New England Journal of Medicine.
365:1284-1292.
2011
|
|
| 2011
|
A Genome-Wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus.
PLoS One.
6.
2011
|
|
| 2011
|
The Alabama drug discovery alliance: A collaborative partnership to facilitate academic drug discovery.
Pharmaceutical Research.
28:1454-1459.
2011
|
|
| 2011
|
Engineered herpes simplex virus vectors for antitumor therapy and vaccine delivery.
Future Virology.
6:321-340.
2011
|
|
| 2011
|
Antiviral drugs and antiviral drug resistance.
Current Opinion in Virology.
1:545-547.
2011
|
|
| 2011
|
Safety and pharmacokinetics of ribavirin for the treatment of la crosse encephalitis
2011
|
|
| 2010
|
Moving toward elimination of healthcare-associated infections: A call to action.
American Journal of Infection Control.
38:671-675.
2010
|
|
| 2010
|
Moving toward elimination of healthcare-associated infections: A call to action.
Infection Control and Hospital Epidemiology.
31:1101-1105.
2010
|
|
| 2010
|
Reply to Johnson and Stricker.
Clinical Infectious Diseases.
51:1109-1110.
2010
|
|
| 2010
|
Treatment of herpes simplex virus infections in pediatric patients: Current status and future needs.
Clinical Pharmacology and Therapeutics.
88:720-724.
2010
|
|
| 2010
|
Oseltamivir dosing for influenza infection in premature neonates.
Journal of Infectious Diseases.
202:563-566.
2010
|
|
| 2010
|
Management of herpes zoster and post-herpetic neuralgia now and in the future.
Journal of Clinical Virology.
48.
2010
|
|
| 2010
|
Herpes simplex virus in African American heterosexual males: The roles of age and male circumcision.
Sexually Transmitted Diseases.
37:217-222.
2010
|
|
| 2010
|
Of ferrets and humans: Influenza pathogenesis.
Journal of Infectious Diseases.
201:976-977.
2010
|
|
| 2010
|
Incomplete financial disclosures in an editorial, clinical crossroads, and reply letter related to herpes zoster.
Journal of the American Medical Association.
303:733-734.
2010
|
|
| 2010
|
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age
2010
|
|
| 2009
|
Inhibition of herpesvirus replication by 5-substituted 4′- thiopyrimidine nucleosides.
Antimicrobial Agents and Chemotherapy.
53:5251-5258.
2009
|
|
| 2009
|
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.
Journal of Clinical Virology.
46.
2009
|
|
| 2009
|
Antiviral therapy for herpesvirus central nervous system infections: Neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.
Antiviral Research.
83:207-213.
2009
|
|
| 2009
|
A 70-year-old woman with shingles: Review of herpes zoster.
Journal of the American Medical Association.
302:73-80.
2009
|
|
| 2009
|
Treatment of recurrent malignant glioma with G207, a genetically engineered herpes simplex virus-1, followed by irradiation: Phase I study results..
Journal of Clinical Oncology.
27:2042.
2009
|
|
| 2009
|
Treatment of congenital cytomegalovirus infection: Implications for future therapeutic strategies.
Journal of Antimicrobial Chemotherapy.
63:862-867.
2009
|
|
| 2009
|
Herpes zoster in the age of focused immunosuppressive therapy.
Journal of the American Medical Association.
301:774-775.
2009
|
|
| 2009
|
In reply.
Journal of the American Medical Association.
302:1862-1863.
2009
|
|
| 2009
|
Phase Ib trial of mutant herpes simplex virus G207 inoculated pre-and post-tumor resection for recurrent GBM.
Molecular Therapy.
17:199-207.
2009
|
|
| 2008
|
Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure.
Liver Transplantation.
14:1498-1504.
2008
|
|
| 2008
|
Therapy of herpes virus infections in children.
Advances in Experimental Medicine and Biology.
609:216-232.
2008
|
|
| 2008
|
The management of encephalitis: Clinical practice guidelines by the Infectious Diseases Society of America.
Clinical Infectious Diseases.
47:303-327.
2008
|
|
| 2008
|
Seasonal and pandemic influenza: A 2007 update on challenges and solutions.
Clinical Infectious Diseases.
46:1024-1031.
2008
|
|
| 2008
|
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.
Journal of Infectious Diseases.
197:836-845.
2008
|
|
| 2008
|
The new age of molecular diagnostics for microbial agents.
New England Journal of Medicine.
358:988-989.
2008
|
|
| 2008
|
Diagnosis and Assessment of Pain Associated With Herpes Zoster and Postherpetic Neuralgia.
Pain Forum.
9:37-44.
2008
|
|
| 2008
|
Neonatal herpes - The forgotten perinatal infection.
Sexually Transmitted Diseases.
35:22-24.
2008
|
|
| 2007
|
(Herpes (2007) 14, SUPPL. 2, (25A-29A)).
Herpes : the journal of the IHMF.
14:74.
2007
|
|
| 2007
|
The incidence and severity of herpes simplex encephalitis in Sweden, 1990-2001.
Clinical Infectious Diseases.
45:881-882.
2007
|
|
| 2007
|
The role of oseltamivir in the treatment and prevention of influenza in children..
Expert Opinion on Drug Metabolism and Toxicology.
3:755-767.
2007
|
|
| 2007
|
HIV-189.6 Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice.
Vaccine.
25:6764-6773.
2007
|
|
| 2007
|
Incidence of neonatal herpes simplex virus infections in a managed-care population.
Sexually Transmitted Diseases.
34:704-708.
2007
|
|
| 2007
|
An update on short-course intermittent and prevention therapies for herpes labialis.
Herpes : the journal of the IHMF.
14.
2007
|
|
| 2007
|
Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation.
Clinical Pharmacology and Therapeutics.
81:867-872.
2007
|
|
| 2007
|
Review of recent HSV recurrent-infection treatment studies.
Herpes : the journal of the IHMF.
14:23-26.
2007
|
|
| 2007
|
Current non-AIDS antiviral chemotherapy.
Expert Review of Anti-infective Therapy.
5:217-230.
2007
|
|
| 2007
|
Varicella-zoster vaccine for the prevention of herpes zoster.
New England Journal of Medicine.
356:1338-1343.
2007
|
|
| 2007
|
Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors.
Cancer Gene Therapy.
14:45-56.
2007
|
|
| 2007
|
Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients.
Clinical Infectious Diseases.
44:245-249.
2007
|
|
| 2007
|
Recommendations for the management of herpes zoster.
Clinical Infectious Diseases.
44.
2007
|
|
| 2007
|
Short-course therapy for recurrent genital herpes and herpes labialis
2007
|
|
| 2007
|
The role of oseltamivir in the treatment and prevention of influenza in children.
Expert Opinion on Drug Metabolism and Toxicology.
3:755-767.
2007
|
|
| 2006
|
Lessons learned from reconstructing the 1918 influenza pandemic.
Journal of Infectious Diseases.
194.
2006
|
|
| 2006
|
Oncolytic HSV-1 for the treatment of brain tumours.
Herpes : the journal of the IHMF.
13:66-71.
2006
|
|
| 2006
|
Prevention and treatment of influenza in high-risk groups: Children, pregnant women, immunocompromised hosts, and nursing home residents.
Journal of Infectious Diseases.
194.
2006
|
|
| 2006
|
Recurrent benign lymphocytic meningitis.
Clinical Infectious Diseases.
43:1194-1197.
2006
|
|
| 2006
|
Seasonal and pandemic influenza preparedness: A global threat.
Journal of Infectious Diseases.
194.
2006
|
|
| 2006
|
Seasonal and pandemic influenza: Recommendations for preparedness in the United States.
Journal of Infectious Diseases.
194.
2006
|
|
| 2006
|
Herpes simplex encephalitis: Adolescents and adults.
Antiviral Research.
71:141-148.
2006
|
|
| 2006
|
New approaches to the therapy of HSV infections.
Herpes : the journal of the IHMF.
13:53-55.
2006
|
|
| 2006
|
Serial passage through human glioma xenografts selects for a Δγ134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors.
Journal of Virology.
80:7308-7315.
2006
|
|
| 2006
|
Enteroviral meningitis: Natural history and outcome of pleconaril therapy.
Antimicrobial Agents and Chemotherapy.
50:2409-2414.
2006
|
|
| 2006
|
Single-day famciclovir therapy for recurrent genital herpes.
Current Medical Research and Opinion.
22:1307-1310.
2006
|
|
| 2006
|
Regulatory challenges: Lessons from recent West Nile virus trials in the United States.
Contemporary Clinical Trials.
27:254-259.
2006
|
|
| 2006
|
The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic.
Journal of Infectious Diseases.
193:905-911.
2006
|
|
| 2006
|
Genetically engineered herpes simplex viruses that express IL-12 or GM-CSF as vaccine candidates.
Vaccine.
24:1644-1652.
2006
|
|
| 2006
|
Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
American Journal of Obstetrics and Gynecology.
194:774-781.
2006
|
|
| 2005
|
Neonatal herpes should be a reportable disease.
Sexually Transmitted Diseases.
32:521-525.
2005
|
|
| 2005
|
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients.
Liver Transplantation.
11:941-949.
2005
|
|
| 2005
|
Historical correlates of genital herpes simplex virus type 2 infection in men attending an STD clinic.
Sexually Transmitted Infections.
81:303-305.
2005
|
|
| 2005
|
Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.
Neuro-Oncology.
7:213-224.
2005
|
|
| 2005
|
Changing dynamics of varicella-zoster virus infections in the 21st century: The impact of vaccination.
Journal of Infectious Diseases.
191:1999-2001.
2005
|
|
| 2005
|
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12.
Cancer Gene Therapy.
12:359-368.
2005
|
|
| 2005
|
The use of dexamethasone in bacterial meningitis [2] (multiple letters).
Clinical Infectious Diseases.
40:1061-1063.
2005
|
|
| 2005
|
Human herpesvirus 6 infection of the central nervous system: Is it just a case of mistaken association?.
Clinical Infectious Diseases.
40:894-895.
2005
|
|
| 2005
|
Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.
Journal of Infectious Diseases.
191:227-233.
2005
|
|
| 2005
|
Herpes simplex: Encephalitis children and adolescents.
Seminars in pediatric infectious diseases.
16:17-23.
2005
|
|
| 2005
|
Neonatal herpes: What have we learned.
Seminars in pediatric infectious diseases.
16:7-16.
2005
|
|
| 2005
|
Seminars in Pediatric Infectious Diseases: Introduction.
Seminars in pediatric infectious diseases.
16:4-5.
2005
|
|
| 2004
|
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America.
Clinical Infectious Diseases.
39:1307-1313.
2004
|
|
| 2004
|
Practice guidelines for the management of bacterial meningitis.
Clinical Infectious Diseases.
39:1267-1284.
2004
|
|
| 2004
|
Commentary: Ch'ien LT, Cannon NJ, Charamella LJ, et al. Effect of adenine arabinoside on severe herpesvirus hominis infections in man: Preliminary report. J Infect Dis 1973; 128:658-63.
Journal of Infectious Diseases.
190:1360-1367.
2004
|
|
| 2004
|
HSV shedding.
Antiviral Research.
63.
2004
|
|
| 2004
|
HSV-2 transmission.
Antiviral Research.
63.
2004
|
|
| 2004
|
Lessons from HIV and hepatitis viruses.
Antiviral Research.
63.
2004
|
|
| 2004
|
Cytomegalovirus and HIV: Inextricably entwined pathogens
2004
|
|
| 2004
|
Herpesvirus infections of the central nervous system.
Herpes : the journal of the IHMF.
11.
2004
|
|
| 2004
|
Neonatal herpes simplex virus infection.
Current Opinion in Infectious Diseases.
17:243-246.
2004
|
|
| 2004
|
Congenital cytomegalovirus infection: Epidemiology and treatment.
Advances in Experimental Medicine and Biology.
549:155-160.
2004
|
|
| 2004
|
Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. 1973..
Journal of Infectious Diseases.
190:1362-1367.
2004
|
|
| 2004
|
Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?.
Antiviral Research.
63.
2004
|
|
| 2004
|
Issues in regulatory guidelines for data monitoring committees.
Clinical Trials.
1:162-169.
2004
|
|
| 2003
|
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial.
Journal of Pediatrics.
143:16-25.
2003
|
|
| 2003
|
Herpes zoster [8] (multiple letters).
New England Journal of Medicine.
348:2044-2045.
2003
|
|
| 2003
|
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis
2003
|
|
| 2003
|
Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis.
2003
|
|
| 2003
|
Smallpox: A potential agent of bioterrorism.
Antiviral Research.
57:7-12.
2003
|
|
| 2002
|
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis.
Journal of Infectious Diseases.
186:1013-1018.
2002
|
|
| 2002
|
Herpes zoster.
New England Journal of Medicine.
347:340-346.
2002
|
|
| 2002
|
The case of the vanishing herpes simplex virus.
Consultant.
42:1092.
2002
|
|
| 2002
|
Herpes simplex viruses: is a vaccine tenable?.
Journal of Clinical Investigation.
110:145-151.
2002
|
|
| 2002
|
Clinical applications for change-point analysis of herpes zoster pain.
Journal of Pain and Symptom Management.
23:510-516.
2002
|
|
| 2002
|
Herpes Simplex Virus in Children..
Current Treatment Options in Neurology.
4:231-237.
2002
|
|
| 2002
|
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma
2002
|
|
| 2002
|
Viral encephalitis: Familiar infections and emerging pathogens
2002
|
|
| 2002
|
Friendly fire: Redirecting herpes simplex virus-1 for therapeutic applications.
Clinical Microbiology and Infection.
8:551-563.
2002
|
|
| 2002
|
Herpes simplex virus infection.
Seminars in pediatric infectious diseases.
13:6-11.
2002
|
|
| 2002
|
Herpes simplex viruses: Is a vaccine tenable?.
Journal of Clinical Investigation.
110:145-151.
2002
|
|
| 2002
|
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma
2002
|
|
| 2001
|
Prevention of hepatitis B in adolescents [12].
Pediatrics.
108:1392.
2001
|
|
| 2001
|
Phase specific analysis of herpes zoster associated pain data: A new statistical approach.
Statistics in Medicine.
20:2429-2439.
2001
|
|
| 2001
|
Natural history of neonatal herpes simplex virus infections in the acyclovir era.
Pediatrics.
108:223-229.
2001
|
|
| 2001
|
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.
Pediatrics.
108:230-238.
2001
|
|
| 2001
|
Natural history of neonatal herpes simplex virus infections in the acyclovir era..
Pediatrics.
108:223-229.
2001
|
|
| 2001
|
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections..
Pediatrics.
108:230-238.
2001
|
|
| 2001
|
Herpes simplex virus infections
2001
|
|
| 2001
|
Genetically engineered human herpes simplex virus in the treatment of brain tumours.
Herpes : the journal of the IHMF.
8:17-22.
2001
|
|
| 2001
|
The nine ages of herpes simplex virus.
Herpes : the journal of the IHMF.
8:23-27.
2001
|
|
| 2001
|
Oral oseltamivir treatment of influenza in children
2001
|
|
| 2001
|
Recommended childhood immunization schedule - United States, January-December 2001.
Pediatrics.
107:202-204.
2001
|
|
| 2001
|
Erratum: Oral oseltamivir treatment of influenza in children (Pediatric Infectious Disease Journal (february 20001) 20:2 (127-133))
2001
|
|
| 2001
|
Immunologic approach to herpes simplex virus.
Viral Immunology.
14:111-118.
2001
|
|
| 2001
|
Oral oseltamivir treatment of influenza in children
2001
|
|
| 2000
|
Our evolving knowledge of herpesviruses.
Herpes : the journal of the IHMF.
7:59.
2000
|
|
| 2000
|
Technical Report: Transmissible spongiform encephalopathies: A review for pediatricians.
Pediatrics.
106:1160-1165.
2000
|
|
| 2000
|
Editorial: Our Evolving Knowledge of Herpesviruses..
Herpes : the journal of the IHMF.
7:59.
2000
|
|
| 2000
|
Genetically engineered HSV in the treatment of glioma: A review.
Reviews in Medical Virology.
10:17-30.
2000
|
|
| 2000
|
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors
2000
|
|
| 2000
|
American Academy of Pediatrics. Technical report: transmissible spongiform encephalopathies: A review for pediatricians. Committee on Infectious Diseases..
Pediatrics.
106:1160-1165.
2000
|
|
| 2000
|
Chemical-biological terrorism and its impact on children: A subject review.
Pediatrics.
105:662-670.
2000
|
|
| 2000
|
HSV resistance - Is there an issue?.
Round Table Series- Royal Society of Medicine.
39-45.
2000
|
|
| 2000
|
Infection control in physicians' offices.
Pediatrics.
105:1361-1369.
2000
|
|
| 2000
|
Introduction.
Round Table Series- Royal Society of Medicine.
1-3.
2000
|
|
| 2000
|
Meningococcal disease prevention and control strategies for practice-based physicians (Addendum: Recommendations for college students).
Pediatrics.
106:1500-1504.
2000
|
|
| 2000
|
Optimizing the management of genital herpes - STD physician's perspective.
Round Table Series- Royal Society of Medicine.
59-66.
2000
|
|
| 2000
|
Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis.
Pediatrics.
106:362-366.
2000
|
|
| 2000
|
Prevention of lyme disease.
Pediatrics.
105:142-147.
2000
|
|
| 2000
|
Recommended Childhood Immunization Schedule - United States, January- December 2000.
Pediatrics.
105:148-151.
2000
|
|
| 2000
|
Varicella vaccine update.
Pediatrics.
105:136-141.
2000
|
|
| 1999
|
Herpes zoster: Focus on treatment in older adults.
Antiviral Research.
44:145-154.
1999
|
|
| 1999
|
Prevention of poliomyelitis: Recommendations for use of only inactivated poliovirus vaccine for routine immunization.
Pediatrics.
104:1404-1406.
1999
|
|
| 1999
|
Effect of recombinant human interferon α B/D (rHu-IFN-α B/D) in combination with acyclovir in experimental HSV-1 encephalitis.
Antiviral Research.
44:75-78.
1999
|
|
| 1999
|
Clinical significance of enteroviruses in serious summer febrile illnesses of children
1999
|
|
| 1999
|
Possible association of intussusception with rotavirus vaccination.
Pediatrics.
104:575.
1999
|
|
| 1999
|
Immunizations for native American children.
Pediatrics.
104:564-567.
1999
|
|
| 1999
|
Possible association of intussusception with rotavirus vaccination. American Academy of Pediatrics. Committee on Infectious Diseases..
Pediatrics.
104:575.
1999
|
|
| 1999
|
A mixed model for factors predictive of pain in AIDS patients with herpes zoster.
Journal of Pain and Symptom Management.
17:410-417.
1999
|
|
| 1999
|
Ionizing radiation improves survival in mice bearing intracranial high- grade gliomas injected with genetically modified herpes simplex virus.
Clinical Cancer Research.
5:1517-1522.
1999
|
|
| 1999
|
New Thoughts on Pathogenesis and Diagnosis of Encephalitis..
Current Infectious Disease Reports.
1:178-186.
1999
|
|
| 1999
|
Measles immunization in HIV-infected children.
Pediatrics.
103:1057-1060.
1999
|
|
| 1999
|
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors.
Cancer Research.
59:2055-2058.
1999
|
|
| 1999
|
Cytomegalovirus retinitis - Evolving therapies in a new era.
New England Journal of Medicine.
340:1109-1110.
1999
|
|
| 1999
|
Herpes zoster: Risk categories for persistent pain.
Journal of Infectious Diseases.
179:9-15.
1999
|
|
| 1999
|
A new role for herpes simplex virus?.
Infectious Diseases in Clinical Practice.
8:93-96.
1999
|
|
| 1999
|
Approaches to the treatment of varicella-zoster virus infections..
Contributions to microbiology.
3:158-172.
1999
|
|
| 1999
|
Poliomyelitis prevention: Revised recommendations for use of inactivated and live oral poliovirus vaccines.
Pediatrics.
103:171-172.
1999
|
|
| 1999
|
Recommended childhood immunization schedule - United States, January- December 1999.
Pediatrics.
103:182-185.
1999
|
|
| 1999
|
Therapeutic approaches to the management of herpes zoster.
Advances in Experimental Medicine and Biology.
458:159-165.
1999
|
|
| 1999
|
Thimerosal in vaccines - An interim report to clinicians.
Pediatrics.
104:570-574.
1999
|
|
| 1999
|
Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: Recommendations of the international AIDS society-USA panel.
American Journal of Ophthalmology.
127:329-339.
1999
|
|
| 1999
|
Viral encephalitis..
Pediatrics in Review.
20:192-198.
1999
|
|
| 1998
|
Comparison of antiviral compounds against human herpesvirus 6 and 7.
Antiviral Research.
40:73-84.
1998
|
|
| 1998
|
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: Recommendations of an international panel.
JAMA Internal Medicine.
158:957-969.
1998
|
|
| 1998
|
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group..
Antimicrobial Agents and Chemotherapy.
42:1139-1145.
1998
|
|
| 1998
|
Summary of the III international consensus symposium on combined antiviral therapy.
Antiviral Research.
38:75-93.
1998
|
|
| 1998
|
Hepatitis C virus infection.
Pediatrics.
101:481-485.
1998
|
|
| 1998
|
Age for routine administration of the second dose of measles-mumps- rubella vaccine.
Pediatrics.
101:129-133.
1998
|
|
| 1998
|
Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis.
Journal of Clinical Microbiology.
36:2229-2234.
1998
|
|
| 1998
|
Erratum: Retraction: A rabbit model for human cytomegalovirus-induced chorioretinal disease (The Journal of Infectious Diseases (1998) 177 (1778)).
Journal of Infectious Diseases.
178:601.
1998
|
|
| 1998
|
Herpes simplex viruses.
Clinical Infectious Diseases.
26:541-555.
1998
|
|
| 1998
|
Human herpesvirus-6: Neurologic implications of a newly-described viral pathogen.
Journal of NeuroVirology.
4:474-485.
1998
|
|
| 1998
|
Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy.
American Journal of Obstetrics and Gynecology.
179:846-851.
1998
|
|
| 1998
|
Prevention of respiratory syncytial virus infections: Indications for the use of palivizumab and update on the use of RSV-IGIV.
Pediatrics.
102:1211-1216.
1998
|
|
| 1998
|
Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine.
Pediatrics.
102:1483-1491.
1998
|
|
| 1998
|
Recommended childhood immunization schedule - United states, January- December 1998.
Pediatrics.
101:154-157.
1998
|
|
| 1998
|
Retraction: A rabbit model for human cytomeglovirus--induced chorioretinal disease (J Infect Dis 1993;168:336-44)..
Journal of Infectious Diseases.
177:1778.
1998
|
|
| 1998
|
Severe invasive group a streptococcal infections: A subject review.
Pediatrics.
101:136-140.
1998
|
|
| 1998
|
Sexually transmitted diseases.
1998
|
|
| 1998
|
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: Results from a randomized, controlled clinical trial.
Antimicrobial Agents and Chemotherapy.
42:1139-1145.
1998
|
|
| 1998
|
The identification of risk factors associated with persistent pain following herpes zoster.
Journal of Infectious Diseases.
178.
1998
|
|
| 1998
|
Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins
1998
|
|
| 1997
|
Antiviral Therapy for Neonatal Herpes Simplex Virus: A Cost-Effectiveness Analysis.
American Journal of Managed Care.
3:1551-1558.
1997
|
|
| 1997
|
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
Cancer Research.
57:1502-1509.
1997
|
|
| 1997
|
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group..
Journal of Infectious Diseases.
175:1080-1086.
1997
|
|
| 1997
|
Recommended childhood immunization schedule - United States, January- December 1997.
Pediatrics.
99:136-138.
1997
|
|
| 1997
|
Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types
1997
|
|
| 1997
|
Respiratory syncytial virus immune globulin intravenous: Indications for use.
Pediatrics.
99:645-650.
1997
|
|
| 1997
|
New therapeutic approaches to the alphaherpesvirus infections.
Journal of Antimicrobial Chemotherapy.
39:119-128.
1997
|
|
| 1997
|
Immunization of adolescents: Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.
Pediatrics.
99:479-488.
1997
|
|
| 1997
|
Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection.
Pediatrics.
99:489-496.
1997
|
|
| 1997
|
Acellular pertussis vaccine: Recommendations for use as the initial series in infants and children.
Pediatrics.
99:282-288.
1997
|
|
| 1997
|
Poliomyelitis prevention: Recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine.
Pediatrics.
99:300-305.
1997
|
|
| 1997
|
Therapy for children with invasive pneumococcal infections.
Pediatrics.
99:289-299.
1997
|
|
| 1997
|
A foot in the door.
Herpes : the journal of the IHMF.
4:54.
1997
|
|
| 1997
|
Acyclovir plus steroids for herpes zoster [5] (multiple letters).
ACP journal club.
126:831-832.
1997
|
|
| 1997
|
Assessment of pain in herpes zoster: Lessons learned from antiviral trials.
Antiviral Research.
33:73-85.
1997
|
|
| 1997
|
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II study.
Journal of Infectious Diseases.
175:1080-1086.
1997
|
|
| 1997
|
Prophylaxis and treatment of herpesvirus infections in children.
Seminars in pediatric infectious diseases.
8:196-204.
1997
|
|
| 1997
|
The management of herpesvirus infections in individuals with human immunodeficiency virus or AIDS.
Antiviral Therapy.
2:25-28.
1997
|
|
| 1997
|
Treatment of viral infections during pregnancy and the neonatal period.
Clinics in Perinatology.
24:267-283.
1997
|
|
| 1996
|
Advances in the treatment of cytamegalovirus retinitis in patients with AIDS.
Current Opinion in Infectious Diseases.
9:411-412.
1996
|
|
| 1996
|
Antiviral therapy: Present approaches, clinical needs, and drug development strategies.
Reviews in Contemporary Pharmacotherapy.
7:91-107.
1996
|
|
| 1996
|
Prevention of hepatitis A infections: Guidelines for use of hepatitis A vaccine and immune globulin.
Pediatrics.
98:1207-1215.
1996
|
|
| 1996
|
Summary of the International Consensus Symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection.
Antiviral Research.
32:119-140.
1996
|
|
| 1996
|
The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors
1996
|
|
| 1996
|
The pathogenesis of AIDS: Lessons learned from other medical conditions.
Infectious agents and disease.
5:231-239.
1996
|
|
| 1996
|
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group..
Annals of Internal Medicine.
125:376-383.
1996
|
|
| 1996
|
Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group..
Antimicrobial Agents and Chemotherapy.
40:2202-2205.
1996
|
|
| 1996
|
Recommended childhood immunization schedule.
Pediatrics.
98:158.
1996
|
|
| 1996
|
Antiviral resistance: Mechanisms, clinical significance, and future implications.
Journal of Antimicrobial Chemotherapy.
37:403-421.
1996
|
|
| 1996
|
A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
Journal of Virological Methods.
58:137-143.
1996
|
|
| 1996
|
Update on tuberculosis skin testing of children.
Pediatrics.
97:282-284.
1996
|
|
| 1996
|
The relationship between pertussis vaccine and central nervous system sequelae: Continuing assessment.
Pediatrics.
97:279-281.
1996
|
|
| 1996
|
Recommended childhood immunization schedule.
Pediatrics.
97:143.
1996
|
|
| 1996
|
Acyclovir with and without Prednisone for the Treatment of Herpes Zoster: A Randomized, Placebo-Controlled Trial.
ACP journal club.
125:376-383.
1996
|
|
| 1996
|
Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial
1996
|
|
| 1996
|
Advances in the management of herpesvirus infections. Introduction..
Seminars in Cutaneous Medicine and Surgery.
15:1-3.
1996
|
|
| 1996
|
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease.
Journal of Infectious Diseases.
174:1162-1167.
1996
|
|
| 1996
|
Differential effect of recombinant human and mouse interferons on replication of herpes simplex virus type 1 in mouse cells.
Antiviral Research.
32:27-34.
1996
|
|
| 1996
|
Drug discovery for human immunodeficiency virus infection: Conquests and hurdles.
Journal of Antimicrobial Chemotherapy.
37:151-159.
1996
|
|
| 1996
|
Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: A meta-analysis of placebo-controlled trials.
Clinical Infectious Diseases.
22:341-347.
1996
|
|
| 1996
|
Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections.
Antimicrobial Agents and Chemotherapy.
40:2202-2205.
1996
|
|
| 1996
|
Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections.
Pediatrics.
97:137-140.
1996
|
|
| 1996
|
Sorivudine: A potent inhibitor of varicella zoster virus replication.
Advances in Experimental Medicine and Biology.
394:41-44.
1996
|
|
| 1996
|
The past as prelude to the future: History, status, and future of antiviral drugs.
Annals of Pharmacotherapy.
30:967-971.
1996
|
|
| 1996
|
Unique clinical trial design: Combination acyclovir plus prednisone therapy of localized zoster in the normal host.
Antiviral Research.
29:67-68.
1996
|
|
| 1995
|
Evolution of therapy for herpes zoster: What's next?.
Current Opinion in Infectious Diseases.
8:453-454.
1995
|
|
| 1995
|
Sorivudine: a promising drug for the treatment of varicella-zoster virus infection..
Neurology.
45:S73-S75.
1995
|
|
| 1995
|
Herpes zoster in patients with human immunodeficiency virus infection--an ever-expanding spectrum of disease..
Clinical Infectious Diseases.
21:989-990.
1995
|
|
| 1995
|
Diagnosis of herpes simplex encephalitis: Application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease.
Journal of Infectious Diseases.
171:857-863.
1995
|
|
| 1995
|
Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group..
Journal of Infectious Diseases.
171:857-863.
1995
|
|
| 1995
|
Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma
1995
|
|
| 1995
|
Antiviral resistance - an emerging problem.
Antiviral Research.
26:365-368.
1995
|
|
| 1995
|
Antiviral resistance in clinical practice.
Antiviral Research.
26:423-438.
1995
|
|
| 1995
|
Assays for antiviral drug resistance.
Antiviral Research.
26:403-413.
1995
|
|
| 1995
|
Editorial response: Herpes zoster in patients with human immunodeficiency virus infection–an ever-expanding spectrum of disease.
Clinical Infectious Diseases.
21:989-990.
1995
|
|
| 1995
|
Guidelines for the prevention and treatment of B-virus infections in exposed persons.
Clinical Infectious Diseases.
20:421-439.
1995
|
|
| 1995
|
Herpes simplex virus infections of the central nervous system: Therapeutic and diagnostic considerations.
Clinical Infectious Diseases.
20:414-420.
1995
|
|
| 1995
|
Herpesvirus infections in persons infected with human immunodeficiency virus.
Clinical Infectious Diseases.
21.
1995
|
|
| 1995
|
Human herpesvirus 6 is associated with focal encephalitis.
Clinical Infectious Diseases.
21:571-576.
1995
|
|
| 1995
|
Models of antiviral resistance.
Antiviral Research.
26:415-422.
1995
|
|
| 1995
|
Molecular mechanisms of antiviral resistance.
Antiviral Research.
26:369-401.
1995
|
|
| 1995
|
Research initiatives in studies of antiviral resistance and consensus points and recommendations.
Antiviral Research.
26:439-452.
1995
|
|
| 1995
|
Sorivudine: A promising drug for the treatment of varicella-zoster virus infection.
Neurology.
45:S73-S75.
1995
|
|
| 1995
|
The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trials.
Contemporary Clinical Trials.
16:408-421.
1995
|
|
| 1995
|
USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: Disease-specific recommendations.
Clinical Infectious Diseases.
21.
1995
|
|
| 1994
|
Antiviral resistance: Do we know what it means?.
Current Opinion in Infectious Diseases.
7:671-673.
1994
|
|
| 1994
|
Penciclovir/famciclovir: Parent and child in the treatment of herpes virus infections.
Expert Opinion on Investigational Drugs.
3:759-761.
1994
|
|
| 1994
|
Herpes simplex virus infections of women and their offspring: Implications for a developed society
1994
|
|
| 1994
|
A rapid protein A binding radioimmunoassay for the evaluation of antiviral agents.
Journal of Virological Methods.
48:273-279.
1994
|
|
| 1994
|
Neonatal herpes simplex virus infections: Is there a role for immunoglobulin in disease prevention and therapy ?
1994
|
|
| 1994
|
Viral Encephalitis: Diagnosis and Treatment.
CNS Drugs.
2:355-366.
1994
|
|
| 1993
|
A Short-Term Clinical Evaluation of L-697,661, a Non-Nucleoside Inhibitor of HIV-1 Reverse Transcriptase.
New England Journal of Medicine.
329:1065-1072.
1993
|
|
| 1993
|
Evaluation of new anti-infective drugs for the treatment of infection with human immunodeficiency virus.
Clinical Infectious Diseases.
17:794-801.
1993
|
|
| 1993
|
Evaluation of new anti-infective drugs for the treatment of infection with human immunodeficiency virus. The European Working Party of the European Society of Clinical Microbiology and Infectious Diseases..
Clinical Infectious Diseases.
17:794-801.
1993
|
|
| 1993
|
A Rabbit Model for Human Cytomegalovirus-Induced Chorioretinal Disease.
Journal of Infectious Diseases.
168:336-344.
1993
|
|
| 1993
|
Antiviral effect of the extract of culture medium of Lentinus edodes mycelia on the replication of herpes simplex virus type 1.
Antiviral Research.
20:293-303.
1993
|
|
| 1993
|
Antiviral therapy: The time has come.
Journal of Medical Virology.
41:1-1.
1993
|
|
| 1993
|
Diabetes insipidus associated with symptomatic congenital cytomegalovirus infection.
Journal of Pediatrics.
122:911-913.
1993
|
|
| 1993
|
Famciclovir/penciclovir workshop: Introduction.
Antiviral Chemistry and Chemotherapy, Supplement.
4:1.
1993
|
|
| 1993
|
Linear single‐dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections.
Clinical Pharmacology and Therapeutics.
53:15-21.
1993
|
|
| 1993
|
Neonatal herpes simplex virus infections.
Journal of Medical Virology.
41:13-21.
1993
|
|
| 1993
|
Prospects for vaccination against herpes simplex virus.
1993
|
|
| 1993
|
Replication, establishment of latency, and induced reactivation of herpes simplex virus γ1 34.5 deletion mutants in rodent models.
Journal of Clinical Investigation.
91:2837-2843.
1993
|
|
| 1993
|
Therapy for varicelia-zoster virus infections: Where do we stand?.
Infectious Diseases in Clinical Practice.
2:100-108.
1993
|
|
| 1993
|
Viral infections in the immunocompromised host.
Current Opinion in Infectious Diseases.
6:417-421.
1993
|
|
| 1992
|
Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis. Infectious Diseases Society of America and the Food and Drug Administration..
Clinical Infectious Diseases.
15 Suppl 1:S182-S188.
1992
|
|
| 1992
|
Evaluation of new anti-infective drugs for the treatment of cryptococcal meningitis. Infectious Diseases Society of America and the Food and Drug Administration..
Clinical Infectious Diseases.
15 Suppl 1:S189-S194.
1992
|
|
| 1992
|
Evaluation of new anti-infective drugs for the treatment of toxoplasma encephalitis. Infectious Diseases Society of America and the Food and Drug Administration..
Clinical Infectious Diseases.
15 Suppl 1:S200-S205.
1992
|
|
| 1992
|
Evaluation of new anti-infective drugs for the treatment of viral encephalitis. Infectious Diseases Society of America and the Food and Drug Administration..
Clinical Infectious Diseases.
15 Suppl 1:S195-S199.
1992
|
|
| 1992
|
Transmission of herpes simplex virus type 1 infection in an intensive care unit.
ACP journal club.
117:584-586.
1992
|
|
| 1992
|
Acyclovir: A Decade Later.
New England Journal of Medicine.
327:782-789.
1992
|
|
| 1992
|
Rigor in clinical trials..
Infectious agents and disease.
1:119-120.
1992
|
|
| 1992
|
Acyclovir in chickenpox.
New England Journal of Medicine.
326:1224-1226.
1992
|
|
| 1992
|
Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group..
Journal of Pediatrics.
120:627-633.
1992
|
|
| 1992
|
Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group..
Journal of Infectious Diseases.
165:450-455.
1992
|
|
| 1992
|
Prevalence of herpes simplex virus antibodies in dental students..
Journal of Dental Education.
56:206-208.
1992
|
|
| 1992
|
Acyclovir treatment of varicella in otherwise healthy adolescents.
Journal of Pediatrics.
120:627-633.
1992
|
|
| 1992
|
Disseminated Herpes Zoster in the Immunocompromised Host: A Comparative Trial of Acyclovir and Vidarabine.
Journal of Infectious Diseases.
165:450-455.
1992
|
|
| 1992
|
Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1.
Antiviral Research.
19:181-192.
1992
|
|
| 1992
|
Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis.
Clinical Infectious Diseases.
15:S182-S188.
1992
|
|
| 1992
|
Evaluation of new anti-infective drugs for the treatment of cryptococcal meningitis.
Clinical Infectious Diseases.
15:S189-SI94.
1992
|
|
| 1992
|
Evaluation of new anti-infective drugs for the treatment of toxoplasma encephalitis.
Clinical Infectious Diseases.
15:S200-S205.
1992
|
|
| 1992
|
Evaluation of new anti-infective drugs for the treatment of viral encephalitis.
Clinical Infectious Diseases.
15:S195-S199.
1992
|
|
| 1992
|
Herpes simplex vaccines..
Biotechnology.
20:223-254.
1992
|
|
| 1992
|
Management of rfcurrency of herpes simplex virus infection in young infants
1992
|
|
| 1992
|
Neonatal herpes simplex virus infections: Pathogenesis and therapy
1992
|
|
| 1992
|
Reply.
Journal of Pediatrics.
121:836-837.
1992
|
|
| 1992
|
Risk of acyclovir therapy in pregnant adolescent [7].
Journal of Pediatrics.
121:836-837.
1992
|
|
| 1992
|
The management of pregnancies complicated by genital infections with herpes simplex virus.
Clinical Infectious Diseases.
15:1031-1038.
1992
|
|
| 1992
|
Therapeutic Approaches to Varicella-Zoster Virus Infections.
Journal of Infectious Diseases.
166:S51-S57.
1992
|
|
| 1991
|
A Controlled Trial of Acyclovir for Chickenpox in Normal Children.
New England Journal of Medicine.
325:1539-1544.
1991
|
|
| 1991
|
Humanized antibodies for antiviral therapy
1991
|
|
| 1991
|
A Controlled Trial Comparing Vidarabine with Acyclovir in Neonatal Herpes Simplex Virus Infection.
New England Journal of Medicine.
324:444-449.
1991
|
|
| 1991
|
Predictors of morbidity and mortality in neonates with herpes simplex virus infections.
New England Journal of Medicine.
324:450-454.
1991
|
|
| 1991
|
Apical expression of herpes simplex virus type 2 glycoproteins in human neuroblastoma cells.
Virology.
185:908-910.
1991
|
|
| 1991
|
Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies.
Journal of Infectious Diseases.
164:1196-1199.
1991
|
|
| 1991
|
Herpes Simplex Virus Infections of the Central Nervous System: Encephalitis and Neonatal Herpes.
Drugs.
42:406-427.
1991
|
|
| 1991
|
Herpes simplex encephalitis: The case against brain biopsy [1].
Journal of Infectious Diseases.
164:426-427.
1991
|
|
| 1991
|
High-level viremia in adults and children infected with human immunodeficiency virus: Relation to disease stage and cd4+lymphocyte levels.
Journal of Infectious Diseases.
164:72-80.
1991
|
|
| 1991
|
Natural history and treatment of varicella-zoster in high-risk populations.
Journal of Hospital Infection.
18:317-329.
1991
|
|
| 1991
|
Perinatal herpes simplex virus infections.
Reviews in Medical Virology.
1:101-110.
1991
|
|
| 1991
|
Predictors of morbidity and mortality in neonates with herpes simplex virus infections.
Obstetrical and Gynecological Survey.
46:451-453.
1991
|
|
| 1991
|
Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: A statistical model and its clinical implications.
Journal of Infectious Diseases.
163:17-22.
1991
|
|
| 1991
|
Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. NIAID Collaborative Antiviral Study Group..
Journal of Infectious Diseases.
163:17-22.
1991
|
|
| 1990
|
Preface
1990
|
|
| 1990
|
Mapping of herpes simplex virus-1 neurovirulence to γ134.5, a gene nonessential for growth in culture.
Science.
250:1262-1266.
1990
|
|
| 1990
|
Viral Encephalitis.
New England Journal of Medicine.
323:242-250.
1990
|
|
| 1990
|
Expression of HSV-1 glycoproteins in tunicamycin-treated monkey kidney cells.
Biochemical and Biophysical Research Communications.
167:1139-1145.
1990
|
|
| 1990
|
Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis
1990
|
|
| 1990
|
Acyclovir: The past ten years.
Advances in Experimental Medicine and Biology.
278:243-253.
1990
|
|
| 1990
|
Chickenpox: Where do we stand with treatment?.
Journal of Pediatrics.
116:587.
1990
|
|
| 1990
|
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys Aotus trivirgatus.
Journal of Infectious Diseases.
162:313-321.
1990
|
|
| 1990
|
Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon.
Viral Immunology.
3:217-224.
1990
|
|
| 1990
|
Long-Term Cognitive Sequelae of Acyclovir-Treated Herpes Simplex Encephalitis.
JAMA Neurology.
47:646-647.
1990
|
|
| 1990
|
Novel Pharmacological Strategies in the Treatment of Life‐Threatening Cytomegalovirus Infections: Clinical Experience with Continuous Infusion 9‐(1,3‐Dihydroxy‐2‐Propoxymethyl) Guanine.
Annals of the New York Academy of Sciences.
616:452-460.
1990
|
|
| 1990
|
Reference Values in Pediatric Medicine.
Mayo Clinic Proceedings.
65:431-435.
1990
|
|
| 1990
|
Treatment of condyloma acuminatum with three different interferon-α preparations administered parenterally: A double-blind, placebocontrolled trial.
Journal of Infectious Diseases.
162:1270-1276.
1990
|
|
| 1990
|
Viral encephalitis
1990
|
|
| 1989
|
Diseases That Mimic Herpes Simplex Encephalitis: Diagnosis, Presentation, and Outcome.
Journal of the American Medical Association.
262:234-239.
1989
|
|
| 1989
|
A role for herpes simplex virus type 1 glycoprotein E in induction of cell fusion.
Journal of General Virology.
70:2157-2162.
1989
|
|
| 1989
|
Editorial.
Computerized Medical Imaging and Graphics.
11:1-2.
1989
|
|
| 1989
|
Effect of recombinant hybrid human interferon on replication and morphogenesis of HSV-1 in monkey cells.
Virus Research.
12:33-41.
1989
|
|
| 1989
|
Immunological alterations associated with recurrent herpes simplex genitalis.
Clinical Immunology.
51:294-302.
1989
|
|
| 1989
|
Intrauterine herpes simplex virus infection.
Birth Defects Research Part A: Clinical and Molecular Teratology.
39:1-10.
1989
|
|
| 1989
|
Teratogen update: Intrauterine herpes simplex virus infection.
Birth Defects Research Part A: Clinical and Molecular Teratology.
39:1-10.
1989
|
|
| 1989
|
Varicella–zoster virus infections: Chronic disease in the immunocompromised host: Evidence for persistent excretion of virus
1989
|
|
| 1988
|
Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial..
American Journal of Medicine.
85:301-306.
1988
|
|
| 1988
|
Herpes simplex virus infections of the central nervous system. A review..
American Journal of Medicine.
85:61-67.
1988
|
|
| 1988
|
The Frustrations of Treating Herpes Simplex Virus Infections of the Central Nervous System.
Journal of the American Medical Association.
259:1067.
1988
|
|
| 1988
|
Neurovirulence in an experimental focal herpes encephalitis: relationship to observed seizures.
Brain Research.
440:293-298.
1988
|
|
| 1988
|
DIFFERENCE BETWEEN HERPES SIMPLEX VIRUS TYPE I AND TYPE 2 NEONATAL ENCEPHALITIS IN NEUROLOGICAL OUTCOME
1988
|
|
| 1988
|
An isoelectric focusing study in herpes simplex virus encephalitis.
Annals of Neurology.
24:227-232.
1988
|
|
| 1988
|
Antibody response of the newborn after herpes simplex virus infection.
Journal of Infectious Diseases.
158:925-933.
1988
|
|
| 1988
|
Antiviral treatment of a serious herpes simplex infection: Encephalitis.
Journal of the American Academy of Dermatology.
18:209-211.
1988
|
|
| 1988
|
Antiviral treatment of a serious herpes simplex infection: encephalitis..
Journal of the American Academy of Dermatology.
18:209-211.
1988
|
|
| 1988
|
Changing patterns of herpes simplex virus infection in neonates.
Journal of Infectious Diseases.
158:109-116.
1988
|
|
| 1988
|
Condylomata acuminata in IDDM..
Diabetes reviews (Alexandria, Va.).
11:295-296.
1988
|
|
| 1988
|
Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome.
Obstetrical and Gynecological Survey.
43:543-545.
1988
|
|
| 1988
|
Ganciclovir - Have we established clinical value in the treatment of cytomegalovirus infections?.
ACP journal club.
108:452-454.
1988
|
|
| 1988
|
Herpes simplex virus infections of the central nervous system. A review.
American Journal of Medicine.
85:61-67.
1988
|
|
| 1988
|
Intravenous acyclovir therapy of first episodes of genital herpes: A multicenter double-blind, placebo-controlled trial.
American Journal of Medicine.
85:301-306.
1988
|
|
| 1988
|
Isolated Cryptococcus neoformans osteomyelitis in an immunocompetent child
1988
|
|
| 1988
|
Natural History and Pathogenesis of Neonatal Herpes Simplex Virus Infections.
Annals of the New York Academy of Sciences.
549:103-117.
1988
|
|
| 1988
|
Neonatal herpes simplex virus infections.
Clinics in Perinatology.
15:903-916.
1988
|
|
| 1988
|
Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins.
1988
|
|
| 1988
|
Questions and answers.
Journal of the American Academy of Dermatology.
18:222-223.
1988
|
|
| 1988
|
Questions and answers.
Journal of the American Academy of Dermatology.
18:207-208.
1988
|
|
| 1988
|
Treatment of condyloma acuminatum with three different interferons administered intralesionallv: a double blind placebo controlled trial.
Obstetrical and Gynecological Survey.
43:701-702.
1988
|
|
| 1988
|
Treatment of condyloma acuminatum with three different interferons administered intralesionally: A double-blind, placebo-controlled trial.
ACP journal club.
108:675-679.
1988
|
|
| 1987
|
Condyloma acuminatum: Epidemiological, clinical and therapeutic aspects.
European Journal of Epidemiology.
3:209-215.
1987
|
|
| 1987
|
Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activity.
Journal of Clinical Immunology.
7:304-311.
1987
|
|
| 1987
|
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: Follow-up.
Pediatrics.
79:76-83.
1987
|
|
| 1987
|
Analysis of immune function in herpes zoster patients: Demonstration and characterization of suppressor cells.
Journal of Immunology.
138:1229-1233.
1987
|
|
| 1987
|
Antiviral therapy and pulmonary disease.
Chest.
91:246-251.
1987
|
|
| 1987
|
Approaches to therapy of viral infections..
Advances in Pediatrics.
34:89-110.
1987
|
|
| 1987
|
Congenital cytomegalovirus: Immunological alterations.
Journal of Medical Virology.
23:41-49.
1987
|
|
| 1987
|
Consensus: Management of the patient with herpes simplex encephalitis
1987
|
|
| 1987
|
Detection of Antibodies to Herpes Simplex Virus in the Cerebrospinal Fluid of Patients with Herpes Simplex Encephalitis.
Journal of Infectious Diseases.
155:38-44.
1987
|
|
| 1987
|
Detection of antigen to herpes simplex virus in cerebrospinal fluid from patients with herpes simplex encephalitis.
Journal of Infectious Diseases.
155:1172-1178.
1987
|
|
| 1987
|
Factors indicative of outcome in a comparative trial of acyclovir and vidarabine for biopsy-proven herpes simplex encephalitis
1987
|
|
| 1987
|
Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture
1987
|
|
| 1987
|
Intrauterine herpes simplex virus infections.
Journal of Pediatrics.
110:97-101.
1987
|
|
| 1987
|
Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease.
Current Eye Research.
6:173-177.
1987
|
|
| 1987
|
Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers.
Antimicrobial Agents and Chemotherapy.
31:1317-1322.
1987
|
|
| 1987
|
Protective immunity against herpetic ocular disease in an outbred mouse model.
Current Eye Research.
6:167-171.
1987
|
|
| 1987
|
T-cell imbalances and NK activity in varicella-zoster virus infections.
Viral Immunology.
1:145-152.
1987
|
|
| 1987
|
The reply.
American Journal of Medicine.
83:194-195.
1987
|
|
| 1987
|
Therapy of viral infections in children..
Advances in pediatric infectious diseases.
2:35-56.
1987
|
|
| 1987
|
Transfusion-associated viral infections.
Current Problems in Pediatric and Adolescent Health Care.
17:395-443.
1987
|
|
| 1987
|
Yes, Brain Biopsy Should Be a Prerequisite for Herpes Simplex Encephalitis Treatment.
JAMA Neurology.
44:1289-1290.
1987
|
|
| 1986
|
Brain biopsy for encephalitis..
Clinical neurosurgery.
33:591-602.
1986
|
|
| 1986
|
Delta hepatitis. An overview..
The Alabama journal of medical sciences.
23:433-436.
1986
|
|
| 1986
|
Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: Characterization of the effector cells.
Journal of Immunology.
136:4243-4248.
1986
|
|
| 1986
|
Herpesvirus Infections of Pregnancy.
New England Journal of Medicine.
314:1255.
1986
|
|
| 1986
|
Neonatal herpes simplex virus infections. Presentation and management.
1986
|
|
| 1986
|
Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis.
New England Journal of Medicine.
314:144-149.
1986
|
|
| 1986
|
A rabbit model of focal herpes simplex encephalitis.
Journal of Infectious Diseases.
153:732-735.
1986
|
|
| 1986
|
Analysis of dna from recurrent genital herpes simplex virus isolates by restriction endonuclease digestion.
Sexually Transmitted Diseases.
13:61-66.
1986
|
|
| 1986
|
CNS diseases associated with varicella zoster virus and herpes simplex virus infection. Pathogenesis and current therapy.
Neurologic Clinics.
4:265-283.
1986
|
|
| 1986
|
Herpesvirus infections in the immunocompromised host: diagnosis and management..
Advances in Experimental Medicine and Biology.
202:95-118.
1986
|
|
| 1986
|
Human antibody response to herpes simplex virus-specific polypeptides after primary and recurrent infection.
Journal of Clinical Microbiology.
23:725-730.
1986
|
|
| 1986
|
Neonatal herpes simplex virus infections. Presentation and management
1986
|
|
| 1986
|
Progressive multifocal leukoencephalopathy: Three patients diagnosed by brain biopsy, with prolonged survival in two.
Neurosurgery.
18:407-414.
1986
|
|
| 1986
|
Replication of varicella zoster virus in Raji cells.
Virus Research.
4:337-342.
1986
|
|
| 1986
|
Studies on herpes simplex virus type 1 glycoproteins using monoclonal antibodies.
Virology.
151:385-389.
1986
|
|
| 1985
|
Herpesvirus Infections of Pregnancy: Herpes Simplex Virus and Varicella–Zoster Virus Infections.
New England Journal of Medicine.
313:1327-1330.
1985
|
|
| 1985
|
Herpesvirus Infections of Pregnancy: Cytomegalovirus and Epstein–Barr Virus Infections.
New England Journal of Medicine.
313:1270-1274.
1985
|
|
| 1985
|
Parvovirus Infection: Chance and Investigation.
New England Journal of Medicine.
313:111-112.
1985
|
|
| 1985
|
Therapy for human herpesvirus infections. A perspective..
The Alabama journal of medical sciences.
22:193-207.
1985
|
|
| 1985
|
DESIGN OF THERAPEUTIC STUDIES IN HERPES SIMPLEX ENCEPHALITIS
1985
|
|
| 1985
|
Design of therapeutic studies in herpes simplex encephalitis
1985
|
|
| 1985
|
Effect of cloned human interferons on protein synthesis and morphogenesis of herpes simplex virus.
Journal of Virology.
56:419-425.
1985
|
|
| 1985
|
High-pressure liquid chromatographic methods for determining arabinosyladenine-5'-monophosphate, arabinosyladenine, and arabinosylhypoxanthine in plasma and urine.
Antimicrobial Agents and Chemotherapy.
28:265-273.
1985
|
|
| 1985
|
Psychosis and herpes simplex encephalitis.
Southern Medical Journal.
78:1347-1350.
1985
|
|
| 1985
|
Reply.
Journal of Infectious Diseases.
151:971.
1985
|
|
| 1985
|
Therapeutic challenges of neonatal herpes simplex virus infection.
Scandinavian journal of infectious diseases. Supplementum.
17:97-106.
1985
|
|
| 1984
|
Diagnosis of viral encephalitis by brain biopsy.
Seminars in Diagnostic Pathology.
1:71-81.
1984
|
|
| 1984
|
Therapeutic approaches to the control of cytomegalovirus infections.
Birth defects original article series.
20:345-352.
1984
|
|
| 1984
|
Medical pathology conference. Headache, fever, abnormal behavior, and dysphasia in an elderly man..
The Alabama journal of medical sciences.
21:399-406.
1984
|
|
| 1984
|
Therapy of human herpesvirus infections.
Clinical Microbiology Newsletter.
6:107-110.
1984
|
|
| 1984
|
Treatment of Herpesvirus Infections.
New England Journal of Medicine.
310:654-655.
1984
|
|
| 1984
|
Dermatitis Due to Larvae of a Soil Nematode, Pelodera strongyloides.
Pediatric Dermatology.
2:33-37.
1984
|
|
| 1984
|
Effect of cloned human interferons on the replication of and cell fusion induced by herpes simplex virus.
Virus Research.
1:81-87.
1984
|
|
| 1984
|
Infections caused by herpes simplex virus in the immunocompromised host: Natural history and topical acyclovir therapy.
Journal of Infectious Diseases.
150:323-329.
1984
|
|
| 1984
|
Prophylactic or anticipatory antiviral therapy for newborns exposed to herpes simplex infection
1984
|
|
| 1984
|
Treatment of human herpesvirus infections with special reference to encephalitis.
Journal of Antimicrobial Chemotherapy.
14:57-74.
1984
|
|
| 1984
|
Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host.
Journal of Infectious Diseases.
149:1-8.
1984
|
|
| 1983
|
Neonatal herpes simplex virus infection: Follow-up evaluation of vidarabine therapy.
Pediatrics.
72:778-785.
1983
|
|
| 1983
|
Vidarabine for Herpes Zoster.
New England Journal of Medicine.
308:526-527.
1983
|
|
| 1983
|
Acyclovir: Mechanism of Action, Pharmacokinetics, Safety and Clinical Applications
1983
|
|
| 1983
|
Elisa for the detection of herpes simplex virus antigens in the cerebrospinal fluid of patients with encephalitis.
Journal of Virological Methods.
7:117-125.
1983
|
|
| 1983
|
Experience with brain biopsy for suspected herpes encephalitis: A review of forty consecutive cases.
Neurosurgery.
12:654-657.
1983
|
|
| 1983
|
Interim summary of mortality in herpes simplex encephalitis and neonatal herpes simplex virus infections: Vidarabine versus acyclovir.
Journal of Antimicrobial Chemotherapy.
12:105-112.
1983
|
|
| 1983
|
Management of infections.
1983
|
|
| 1983
|
Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies..
Journal of Infectious Diseases.
147:1119-1120.
1983
|
|
| 1983
|
Thymic Hyperplasia in a case of Hodgkin’s Disease.
Southern Medical Journal.
76:1189-1192.
1983
|
|
| 1983
|
Towards therapy and prevention of herpetic infections.
Seminars in Perinatology.
7:64-81.
1983
|
|
| 1982
|
DNA Restriction-Enzyme Analysis of Herpes Simplex Virus Isolates Obtained from Patients with Encephalitis.
New England Journal of Medicine.
307:1060-1062.
1982
|
|
| 1982
|
Early Vidarabine Therapy to Control the Complications of Herpes Zoster in Immunosuppressed Patients.
New England Journal of Medicine.
307:971-975.
1982
|
|
| 1982
|
REPEATED SUPPRESSION OF CREUTZFELDT-JAKOB DISEASE WITH VIDARABINE
1982
|
|
| 1982
|
In Reply.
Journal of the American Medical Association.
248:547-548.
1982
|
|
| 1982
|
Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents.
American Journal of Medicine.
73:236-240.
1982
|
|
| 1982
|
Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.
American Journal of Medicine.
73:165-171.
1982
|
|
| 1982
|
Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals..
American Journal of Medicine.
73:165-171.
1982
|
|
| 1982
|
HERPES SIMPLEX ENCEPHALITIS AND CLINICAL TRIAL DESIGN
1982
|
|
| 1982
|
Herpes simplex encephalitis. Clinical assessment.
Journal of the American Medical Association.
247:317-320.
1982
|
|
| 1982
|
Herpes Simplex Encephalitis: Clinical Assessment.
Journal of the American Medical Association.
247:317-320.
1982
|
|
| 1982
|
Herpes simplex virus encephalitis: Laboratory evaluations and their diagnostic significance.
Journal of Infectious Diseases.
145:829-836.
1982
|
|
| 1982
|
Herpesvirus infections in childhood: Diagnostic dilemmas and therapy
1982
|
|
| 1982
|
Vidrabine therapy of varicella in immunosuppressed patients.
Journal of Pediatrics.
101:125-131.
1982
|
|
| 1981
|
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: A prospective study.
Pediatrics.
68:322-329.
1981
|
|
| 1981
|
Herpes Simplex Encephalitis.
New England Journal of Medicine.
304:1236-1237.
1981
|
|
| 1981
|
Herpes Simplex Encephalitis: Vidarabine Therapy and Diagnostic Problems.
New England Journal of Medicine.
304:313-318.
1981
|
|
| 1981
|
Antiviral agents: clinical status report.
Hospital practice (Office ed.).
16:109-121.
1981
|
|
| 1981
|
Diagnosis and treatment of herpes simplex encephalitis..
Annual Review of Medicine.
32:335-340.
1981
|
|
| 1981
|
Preventive and therapeutic approaches to the newborn infant with perinatal viral and toxoplasma infections.
Clinics in Perinatology.
8:591-604.
1981
|
|
| 1981
|
Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy.
Infection and Immunity.
34:166-170.
1981
|
|
| 1981
|
The natural history of herpes simplex virus infection of mother and newborn.
Obstetrical and Gynecological Survey.
36:359-361.
1981
|
|
| 1981
|
Virology findings in progressive multifocal leukoencephalopathy..
The Alabama journal of medical sciences.
18:68.
1981
|
|
| 1980
|
The natural history of herpes simplex virus infection of mother and newborn.
Pediatrics.
66:489-494.
1980
|
|
| 1980
|
Vidarabine therapy of neonatal herpes simplex virus infection.
Pediatrics.
66:495-501.
1980
|
|
| 1980
|
Herpes Simplex Encephalitis: Need for Accurate Diagnosis.
Journal of the American Medical Association.
244:371-372.
1980
|
|
| 1980
|
Adenine arabinoside therapy of neonatal herpes simplex viral infection.
Pediatric Research.
14.
1980
|
|
| 1980
|
Cytomegalovirus infection in patients with renal transplants: Potentiation by antithymocyte globulin and an incompatible graft.
Journal of Infectious Diseases.
142:9-17.
1980
|
|
| 1980
|
Herpes Zoster in Early Infancy.
JAMA Pediatrics.
134:618-619.
1980
|
|
| 1980
|
Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans.
Antimicrobial Agents and Chemotherapy.
18:709-715.
1980
|
|
| 1980
|
Plasma levels and urinary excretion of vidarabine after repeated dosing.
Clinical Pharmacology and Therapeutics.
27:690-696.
1980
|
|
| 1980
|
Vidarabine: A Preliminary Review of its Pharmacological Properties and Therapeutic Use.
Drugs.
20:267-282.
1980
|
|
| 1979
|
Developmental aspects of adenine arabinoside for parenteral therapy of human herpesvirus infections..
Advances in ophthalmology = Fortschritte der Augenheilkunde = Progres en ophtalmologie.
38:288-296.
1979
|
|
| 1979
|
Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation..
Transplantation.
28:443-446.
1979
|
|
| 1979
|
Outcome of renal transplantation in patients with primary cytomegalovirus infection.
Transplantation Proceedings.
11:1288-1290.
1979
|
|
| 1979
|
Distribution of Adenine Arabinoside and Interferon.
Journal of the American Medical Association.
242:1259-1260.
1979
|
|
| 1979
|
Acyclovir kinetics after intravenous infusion.
Clinical Pharmacology and Therapeutics.
26:718-728.
1979
|
|
| 1979
|
Distribution of adenine arabinoside and interferon.
Journal of the American Medical Association.
242:1159-1160.
1979
|
|
| 1979
|
Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation.
Transplantation.
27:443-450.
1979
|
|
| 1979
|
Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation.
Journal of Infectious Diseases.
140:487-492.
1979
|
|
| 1979
|
Serum Antibody Levels as Risk Factors in the Dissemination of Herpes Zoster.
JAMA Internal Medicine.
139:1341-1345.
1979
|
|
| 1978
|
NIH conference. Herpes zoster-varicella infections in immunosuppressed patients..
ACP journal club.
89:375-388.
1978
|
|
| 1978
|
Current status of antiviral chemotherapy.
Southern Medical Journal.
71:1134-1140.
1978
|
|
| 1978
|
Developmental aspects of selected antiviral chemotherapeutic agents..
Annual Review of Microbiology.
32:285-300.
1978
|
|
| 1978
|
Herpes simplex virus encephalitis: An atypical presentation.
Southern Medical Journal.
71:1431-1433.
1978
|
|
| 1978
|
Herpes zoster-varicella infections in immunosuppressed patients.
Annals of Internal Medicine.
89:375-388.
1978
|
|
| 1978
|
Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: Role of source of kidney.
Journal of Infectious Diseases.
137:556-563.
1978
|
|
| 1978
|
Purification and characterization of proteins excreted by cells infected with herpes simplex virus and their use in diagnosis.
Virology.
91:234-242.
1978
|
|
| 1977
|
Ara-A for Herpes Encephalitis.
New England Journal of Medicine.
297:1288-1290.
1977
|
|
| 1977
|
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis..
Journal of the Medical Association of the State of Alabama.
47:37-66.
1977
|
|
| 1977
|
Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex Encephalitis: National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study.
New England Journal of Medicine.
297:289-294.
1977
|
|
| 1977
|
Adenine arabinoside therapy of herpes simplex encephalitis: NIAID collaborative antiviral study group.
Pediatric Research.
11.
1977
|
|
| 1977
|
Adenine arabinoside therapy of varicella zoster in immunocompromised patients.
Pediatric Research.
11.
1977
|
|
| 1976
|
Cerebellar hypoplasia in an infant with congenital cytomegalovirus infection.
Pediatrics.
57:155-157.
1976
|
|
| 1976
|
Therapy of herpetic infections in man: a status report..
Advances in pathobiology.
159-172.
1976
|
|
| 1976
|
Treatment of infections due to Herpesvirus in humans: a critical review of the state of the art..
Journal of Infectious Diseases.
133 Suppl:A101-A108.
1976
|
|
| 1976
|
Adenine Arabinoside Therapy of Herpes Zoster in the Immunosuppressed: NIAID Collaborative Antiviral Study.
New England Journal of Medicine.
294:1193-1199.
1976
|
|
| 1976
|
Adenine Arabinoside for Therapy of Herpes Zoster in Immunosuppressed Patients: Preliminary Results of a Collaborative Study.
Journal of Infectious Diseases.
133:A184-A191.
1976
|
|
| 1976
|
Protracted pneumonitis in young infants associated with perinatally acquired cytomegaloviral infection.
Journal of Pediatrics.
89:16-22.
1976
|
|
| 1976
|
Protracted pneumonitis in young infants associated with perinatally acquired cytomegaloviral infection.
Journal of Pediatrics.
89:16-22.
1976
|
|
| 1975
|
Antiviral chemotherapy and neonatal herpes simplex virus infection: a pilot study. Experience with adenine arabinoside (ARA-A).
Pediatrics.
55:678-685.
1975
|
|
| 1975
|
Neonatal herpes simplex virus infection.
International Ophthalmology Clinics.
15:141-149.
1975
|
|
| 1974
|
Adenine arabinoside (ARA-A) and neonatal herpes simplex virus infection.
Clinical research.
22.
1974
|
|
| 1974
|
Effect of adenine arabinoside on cytomegalovirus infections.
Journal of Infectious Diseases.
130:32-39.
1974
|
|
| 1973
|
Effect of adenine arabinoside on severe herpesvirus hominis infections in man.
Journal of Infectious Diseases.
128:658-663.
1973
|
|
